HUP0104308A2 - Amidino- és guanidino-azetidinon-származékok, mint triptáz inhibitorok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények, valamint intermedierek - Google Patents

Amidino- és guanidino-azetidinon-származékok, mint triptáz inhibitorok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények, valamint intermedierek

Info

Publication number
HUP0104308A2
HUP0104308A2 HU0104308A HUP0104308A HUP0104308A2 HU P0104308 A2 HUP0104308 A2 HU P0104308A2 HU 0104308 A HU0104308 A HU 0104308A HU P0104308 A HUP0104308 A HU P0104308A HU P0104308 A2 HUP0104308 A2 HU P0104308A2
Authority
HU
Hungary
Prior art keywords
group
guanidino
amidino
intermediates
preparation
Prior art date
Application number
HU0104308A
Other languages
English (en)
Inventor
Gregory Bisacchi
David R. Kronenthal
Michael E. Randazzo
Mark D. Schwinden
Steven Seiler
Zhongping Shi
William A. Slusarchik
James C. Sutton
Uwe Treuner
Zhongmin Xu
Robert Zahler
Original Assignee
Bristol-Myers Squibb Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Co. filed Critical Bristol-Myers Squibb Co.
Publication of HUP0104308A2 publication Critical patent/HUP0104308A2/hu
Publication of HUP0104308A3 publication Critical patent/HUP0104308A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A tal lm ny t rgy t és ltal nos képletű azetidinsz rmazékok - aholelőny"sen R1 adott esetben észteresített vagy amid lt karboxicsoportvagy bizonyos megk"téssel alkilcsoport; R2 és R3 hidrogénatom, vagyegyikük alkilcsoport; R11 és R12 alkilcsoport; A1 ltal nos képletűcsoport, ahol t = 2, és u = 1; q értéke 1-6; és X1 szubsztitu ltacil-, szulfonil- vagy karbamoilcsoport, főleg 4-szubsz- titu lt 1-piperazinkarbonilcsoport és sóik, ezeket tartalmazó pl. gyullad sok, szív és érrendszerimegbetegedések kezelésére szolg ló gyógyszerkészítmények, elő llít sukés k"ztitermékeik képezik. Ó
HU0104308A 1998-06-25 1999-06-18 Amidino and guanidino azetidinone derivatives as tryptase inhibitors, process for their preparation, pharmaceutical compositions thereof and intermediates HUP0104308A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9063698P 1998-06-25 1998-06-25
PCT/US1999/013811 WO1999067215A1 (en) 1998-06-25 1999-06-18 Amidino and guanidino azetidinone tryptase inhibitors

Publications (2)

Publication Number Publication Date
HUP0104308A2 true HUP0104308A2 (hu) 2002-04-29
HUP0104308A3 HUP0104308A3 (en) 2002-06-28

Family

ID=22223632

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0104308A HUP0104308A3 (en) 1998-06-25 1999-06-18 Amidino and guanidino azetidinone derivatives as tryptase inhibitors, process for their preparation, pharmaceutical compositions thereof and intermediates

Country Status (24)

Country Link
EP (1) EP1089973B1 (hu)
JP (1) JP2002518478A (hu)
KR (1) KR20010053173A (hu)
CN (1) CN1202081C (hu)
AR (1) AR018945A1 (hu)
AT (1) ATE309211T1 (hu)
AU (1) AU752320B2 (hu)
BR (1) BR9911373A (hu)
CA (1) CA2336003A1 (hu)
DE (1) DE69928257T2 (hu)
ES (1) ES2249017T3 (hu)
HU (1) HUP0104308A3 (hu)
ID (1) ID27137A (hu)
IL (1) IL140414A0 (hu)
NO (1) NO20006380D0 (hu)
NZ (1) NZ507627A (hu)
PE (1) PE20000729A1 (hu)
PL (1) PL345067A1 (hu)
RU (1) RU2211832C2 (hu)
TR (1) TR200003859T2 (hu)
TW (1) TW548270B (hu)
UY (1) UY25580A1 (hu)
WO (1) WO1999067215A1 (hu)
ZA (1) ZA200006028B (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1698375B1 (en) 2003-12-25 2014-04-02 Ono Pharmaceutical Co., Ltd. Azetidine ring compounds and drugs comprising the same
WO2006062110A1 (ja) * 2004-12-06 2006-06-15 Banyu Pharmaceutical Co., Ltd. ピペラジン誘導体
US8772297B2 (en) * 2010-02-17 2014-07-08 Kyoto University TGF-β signal transduction inhibitor
TW201514143A (zh) * 2013-03-20 2015-04-16 Hoffmann La Roche 新穎脲衍生物
US20160068486A1 (en) 2013-04-22 2016-03-10 Reuter Chemische Apparatebau Kg Process for preparing enantiomerically enriched 3-hydroxymethylpiperidine
EP3036219A4 (en) * 2013-06-04 2017-08-23 Temple University Of The Commonwealth System Of Higher Education Novel beta lactams as modulators of glutamate uptake and methods for use thereof
ES2945905T3 (es) * 2014-02-07 2023-07-10 Exithera Pharmaceuticals Inc Compuestos y composiciones terapéuticos
EP3749662A4 (en) 2018-02-07 2021-07-14 Exithera Pharmaceuticals Inc. COMPOUNDS AND THERAPEUTIC COMPOSITIONS
WO2019185046A1 (zh) * 2018-03-30 2019-10-03 上海美悦生物科技发展有限公司 四元内酰胺类化合物及其药学用途
CN109988098A (zh) * 2019-05-23 2019-07-09 常州工程职业技术学院 一种(r)-n-叔丁氧羰基-3-羟甲基哌啶的合成方法
CN114040908A (zh) * 2019-06-25 2022-02-11 广东东阳光药业有限公司 一种凝血因子XIa抑制剂的晶型及其制备方法
CN114929869A (zh) 2019-11-08 2022-08-19 科亚韦治疗公司 修饰的腺相关病毒载体及将其递送至中枢神经系统
WO2022096681A1 (en) * 2020-11-06 2022-05-12 Coave Therapeutics Lactam-modified adeno-associated virus vectors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175283A (en) * 1990-06-04 1992-12-29 Bristol-Myers Squibb Company Azetidin-2-one derivatives as serine protease inhibitors
US5110812A (en) * 1990-06-04 1992-05-05 Bristol-Myers Squibb Co. Azetidin-2-one derivatives as serine protease inhibitors
US5250677A (en) * 1990-06-04 1993-10-05 Bristol-Myers Squibb Company Azetidin-2-one derivatives as serine protease inhibitors
US5037819A (en) * 1990-06-04 1991-08-06 Bristol-Myers Squibb Company Azetidin-2-one derivatives as serine protease inhibitors
US5747485A (en) * 1995-04-13 1998-05-05 Merck & Co., Inc. Substituted azetidiones as anti-inflammatory and antidegenerative agents
EP0950046B1 (en) * 1996-09-23 2002-04-10 Naeja Pharmaceutical Inc. 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators

Also Published As

Publication number Publication date
AR018945A1 (es) 2001-12-12
RU2211832C2 (ru) 2003-09-10
DE69928257D1 (de) 2005-12-15
ID27137A (id) 2001-03-01
WO1999067215A1 (en) 1999-12-29
EP1089973A1 (en) 2001-04-11
TR200003859T2 (tr) 2001-07-23
CN1202081C (zh) 2005-05-18
AU4695099A (en) 2000-01-10
PL345067A1 (en) 2001-12-03
AU752320B2 (en) 2002-09-12
PE20000729A1 (es) 2000-10-28
KR20010053173A (ko) 2001-06-25
NO20006380L (no) 2000-12-14
NZ507627A (en) 2003-12-19
EP1089973B1 (en) 2005-11-09
EP1089973A4 (en) 2001-12-12
NO20006380D0 (no) 2000-12-14
UY25580A1 (es) 2001-08-27
ES2249017T3 (es) 2006-03-16
ZA200006028B (en) 2002-09-25
ATE309211T1 (de) 2005-11-15
BR9911373A (pt) 2001-09-18
IL140414A0 (en) 2002-02-10
DE69928257T2 (de) 2006-08-03
TW548270B (en) 2003-08-21
HUP0104308A3 (en) 2002-06-28
JP2002518478A (ja) 2002-06-25
CN1307560A (zh) 2001-08-08
CA2336003A1 (en) 1999-12-29

Similar Documents

Publication Publication Date Title
DE59402222D1 (de) Substituierte heterocyclische Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
DK0778834T3 (da) Bicykliske, heterocykliske diarylforbindelser som inhibitorer af cyclooxygenase-2
DE69931393D1 (de) Antithrombotische amide
MY102866A (en) Amide derivatives.
ATE306261T1 (de) Antithrombosemittel
DE69919212D1 (de) Aromatische amiden
NO986055L (no) Nye heterocykliske forbindelser, deres fremstilling, farmas°ytiske preparater inneholdende forbindelsene og deres anvendelse ved behandling av diabetes og beslektede sykdommer
IL162498A (en) Alpha-(n-sulphonamido) acetamide derivatives and pharmaceutical compositions containing the same
HUP0104308A2 (hu) Amidino- és guanidino-azetidinon-származékok, mint triptáz inhibitorok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények, valamint intermedierek
ATE148108T1 (de) Beta,beta-dimethyl-4-piperidinethanamin-derivat als inhibitoren der cholesterin-biosynthese
AU2364000A (en) Heterocyclic amides as inhibitors of factor xa
EA200400708A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
HUP0402515A2 (hu) Szubsztituált új N-[4-(1H-imidazol-1-il)-2-fluor-fenil]-3-(trifluor-metil)-1H-pirazol-5-karboxamidok Xa faktor inhibitorok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
WO2003066594A3 (de) 3-alkanoylamino-propionsäure-derivate als inhibitoren des integrins avss6
DE69616825D1 (en) Triazolone als apolipoprotein-b synthese ihibitoren
MXPA05014068A (es) Dicetopiperazinas sustituidas y su uso como antagonistas de oxitocina.
MY129537A (en) Amino acid ester containing azole antifungals
EP1027051A4 (en) ANTITHROMBOTIC AGENTS
HUP0203161A2 (hu) Benzamidinszármazékok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
WO2003018564A1 (fr) Inhibiteur d'acat selectif de la paroi vasculaire
WO2003104189A3 (en) COMPOUNDS
NO20052413L (no) Substituted aralkyl derivatives
AU1434201A (en) Antithrombotic agents
ATE268768T1 (de) Antithrombosemittel
MX9704667A (es) 6-[triazolil[3-trifluorometil)fenil]metil]-2-quinolinonas y quinolinotionas.

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees